SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced initiation of a Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback